Kjell Kirschbaum, M.Sc., is a Global Market Manager based in QIAGEN’s Venlo office, the Netherlands. He trained as a bioveterinary scientist at the University of Utrecht and has hands-on experience in nucleic acid and protein purification, cell culture, PCR and qPCR technology. Kjell joined QIAGEN in 2011 as a CRM specialist, regularly interacting with customers about their day-to-day experimental needs and offering relevant solutions. Currently, he is involved in managing global projects for sample preparation and automation technologies.
Determining the purity and concentration of nucleic acid samples is an essential application in molecular biology today. One of the greatest challenges is ensuring that each nucleic acid sample has an adequate concentration and that any chemical contaminants or other impurities are detected. Several analysis instruments are available for this purpose, including QIAGEN’s QIAxpert System…. Read article →
One of the things that immediately comes to mind when I think about Australia – besides kangaroos, dingoes, wombats, the great barrier reef, the Sydney opera house and Men at Work’s famous tune “Down Under” – is of course the cuddly and iconic koala. These creatures are special in many ways. Not only are they… Read article →
New customizable plug-and-play software for the Rotor-Gene Q simplifies workflow and analysis Q-Rex consists of a core software that drives the RGQ hardware. It enables experiment setup, data acquisition and performs basic analyses, plus a suite of plug-ins that expand the capacity of Q-Rex with specific analytical capabilities. It allows you to easily create the… Read article →
In science, the buzz around the reproducibility topic has been going on for some time now. Back in 2010 an article in The New Yorker called “The Truth Wears Off” addressed the concern of which results to believe when so-called validated findings could not be proven or replicated and led to retraction of scientific publications…. Read article →
The importance of circulating tumor cells (CTCs) in cancer research is broadly accepted in the scientific community today. Since CTCs undergo phenotypic changes known as the epithelial-to-mesenchymal transition (EMT), they are a valuable indicator for disease progression and therapy resistance. To learn from CTCs, we must be able to effectively detect and characterize them. There… Read article →
Looking for minireviews, pathway maps, publications and research solutions for specific genes and pathways? Just go to GeneGlobe! 